Ipsen Delivers a Strong Sales Performance in the First Quarter Of 2022
North America sales comprised 32.9% of total sales in the quarter (Q1 2021: 33.8%).
- North America sales comprised 32.9% of total sales in the quarter (Q1 2021: 33.8%).
- Sales in Europe comprised 44.3% of total sales in the quarter (Q1 2021: 47.2%).
- Sales reached 156.9m in the quarter, an increase of 35.4%6, driven by solid volumes growth in Oncology and Neuroscience.
- Rest of the World sales comprised 22.8% of total sales in the quarter (Q1 2021: 18.9%).